Laura Carter - 25 Oct 2021 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Scientific Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
25 Oct 2021
Net transactions value
-$29,118
Form type
4
Filing time
26 Oct 2021, 17:01:26 UTC
Previous filing
01 Jul 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale $29,118 -2,377 -2.4% $12.25* 95,306 25 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.